Cancer research - Strategic Insights Report (Page 26)

Cancer research

Identification of Progression-Associated Biomarkers in Lung Cancer Based on Integrated Analysis of RNA Sequencing Data From Platelets and Tumor Tissues

Researchers at the Second Affiliated Hospital in Xiamen, Fujian, People's Republic of China, have identified 53 platelet-derived genes that are persistently dysregulated throughout the progression of lung cancer. These genes were primarily enriched in ribosome biogenesis-related functions and were found to be associated with poor prognosis in lung

Cancer research

Immunotherapy Shows Promise in Treating Liver Cancer

A groundbreaking study published in the JAMA Oncology journal has investigated the effectiveness of immunotherapy versus best supportive care in treating patients with hepatocellular cancer and Child-Pugh class B liver dysfunction. The research, conducted by a team of researchers from Imperial College London, examined the outcomes of patients who received

Cancer research

Research Reveals Crucial Role of Dicer1 in Thyroid Cancer Progression

A groundbreaking study from the University Libre de Bruxelles in Brussels, Belgium, has shed new light on the complex mechanisms underlying thyroid cancer. The research, published in the journal Cells, found that the RNA-binding protein Dicer1 plays a pivotal role in the development and progression of papillary thyroid carcinoma (PTC)

Cancer research

ESMO-MCBS Scale Evaluates Clinical Benefit of Radiotherapy in Non-Small Cell Lung Cancer Treatment

Studies have shown that radiotherapy is a valuable treatment option for patients with extracranial oligometastatic non-small cell lung cancer (NSCLC), with significant improvements in survival rates. Researchers at Dartmouth-Hitchcock Medical Center evaluated the clinical benefit of radiotherapy in NSCLC patients using the European Society of Medical Oncology (ESMO) magnitude of

Cancer research

COVID-19 Pandemic's Impact on Lung Cancer Diagnosis, Treatment, and Survival in Belgium

A recent study from the Belgian Cancer Registry evaluated the effects of the COVID-19 pandemic on lung cancer diagnosis, treatment, mortality, and survival in Belgium. The research analyzed 29,721 lung cancer patients diagnosed between 2017 and 2020, with a focus on those diagnosed in 2020 during the pandemic. The

Cancer research

Dendritic Cell-Related Gene Signature Identifies Pancreatic Cancer Subtypes and KCTD14-TNF Signaling Axis

Pancreatic cancer, characterized by a profoundly immunosuppressive tumor microenvironment, has a poor prognosis. Researchers at the Sichuan Cancer Hospital studied the role of dendritic cells (DCs) in pancreatic cancer and identified a novel DC-related gene signature that stratifies patient subtypes and implicates a KCTD14-TNF signaling axis. This study provides a

Cancer research

Notch Gene Receptors Linked to Increased Risk of Colorectal Cancer

Researchers at the Govind Ballabh Pant Institute of Postgraduate Medical Education and Research (GIPMER) in New Delhi, India, have investigated the role of Notch gene receptors in colorectal cancer (CRC) development. The study, published in Scientific Reports, found that polymorphisms in Notch1, Notch2, Notch3, and Notch4 genes are associated with

Cancer research

Metastatic Lung Cancer Research Reveals Immunotherapy Breakthroughs

Researchers from the First Affiliated Hospital of Zhengzhou University have discovered that immunotherapy can be enhanced to treat metastatic lung cancer. The study, published in Cancer Immunology, Immunotherapy, found that tumor-associated macrophages (TAMs) contribute to immune suppression in lung cancer by limiting the activation of CD8 T cells and cytokine

Cancer research

New Combination of Drugs Shows Promise in Treating Advanced Prostate Cancer

Researchers at the Institute of Cancer Research, London, have discovered that a combination of two targeted drugs may help treat up to two in five advanced prostate cancer patients. The drugs, which are already in development or approved for use in other cancers, were found to slow tumour growth and

Cancer research

Researchers Identify TGF-b Activity as Prognostic Biomarker for Prostate Cancer Recurrence

Prostate cancer patients with intermediate-to-high-risk disease treated with external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) often experience biochemical recurrence (BCR). New research from the National Cancer Institute (NCI) has identified TGF-b activity as a dominant feature of these tumors, potentially serving as an independent prognostic biomarker for BCR.

Cancer research

Comprehensive Management of Type 2 Diabetes in Gastric Cancer Patients

Research has identified the critical need for stage-specific glycemic management in patients with gastric cancer undergoing surgery. According to a recent study published in Gastric Cancer, a comprehensive approach to glycemic care is essential for improving metabolic and oncologic outcomes. This includes predicting type 2 diabetes remission, evaluating antidiabetic medications,

Cancer research

Advanced Lung Cancer Inflammation Index Predicts Colon Cancer Risk in Elderly Patients

Researchers have identified the Advanced Lung Cancer Inflammation Index (ALI) as a valuable predictor of colon cancer risk in elderly patients. By incorporating body mass index (BMI), serum albumin, and neutrophil-to-lymphocyte ratio (NLR), the ALI composite index reflects both nutritional and systemic inflammatory states. The study, conducted by a team

See all